You are here: Industry Insights > UK

News List

UK babies to be routinely immunised against hepatitis B pharmafile
August 02, 2017
As of today, all babies born in the UK will be administered with the vaccine for hepatitis B, with the jab being added to the five-in-one jab used for routine immunisations in newborns.
EMA unveils business continuity plan ahead of UK exit from EU firstwordpharma
August 02, 2017
The European Medicines Agency on Tuesday revealed its business continuity plan ahead of its relocation from the UK as part of the country's decision to leave the EU.
GSK to invest additional £140m at UK manufacturing sites pharmaceutical-technology
July 21, 2017
GlaxoSmithKline (GSK) is set to invest more than £140m at its production facilities in the UK to improve the efficiency and competitiveness of its manufacturing network.
Arvato Systems signs deal with SecurMed UK to deliver medicines verification in the UK europeanpharmaceuticalreview
July 20, 2017
SecurMed UK, the UK Medicines Verification Organisation, is entering into a Letter of Intent with Arvato Systems as its IT blueprint service provider.
UK trails behind EU in cancer diagnosis & treatment europeanpharmaceuticalreview
July 19, 2017
A new report shows that the UK is trailing behind the rest of Europe in the diagnosis and treatment of cancer.
UK Supreme Court rules in Lilly's favour on Alimta vitamin regimen patents cphi-online
July 13, 2017
Actavis's products directly infringe Lilly's vitamin regimen patents in the UK, France, Italy and Spain.
GNH India clears audit to trade orphan drugs with UK expressbpd
July 11, 2017
Orphan drugs such as Ferripox, Raxone, Trientine and Mitocin will now available to the Indian population.
Study predicts 1.2 million people in UK will be living with dementia by 2040 europeanpharmaceuticalreview
July 06, 2017
By 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), due to increased life expectancy…
ABPI respond to statement of UK Government’s medicines regulation plans pharmaasia
July 05, 2017
The ABPI has responded to a joint letter from Jeremy Hunt, Secretary of State for Health, and Greg Clark, Secretary of State for Business, published by the Financial Times, that outlined the UK Government’s plans for the regulation of medicines as the UK
UK trial for new bladder cancer therapy pharmatimes
June 28, 2017
An experimental therapy for bladder cancer in on the brink of entering Phase I clinical trials in the UK after a development pact was signed between Cancer Research UK, its commercial arm Cancer Research Technology, and Canadian biotech Sitka Biopharma.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page